首页> 美国卫生研究院文献>Journal of Allergy >Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity
【2h】

Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity

机译:NSAID超敏反应患者嗜碱性粒细胞和单核细胞诱导CD63上调的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. An in vitro basophil activation test, based on the detection of CD63 upregulation induced by NSAIDs, has been described. Its clinical significance remains controversial. Objectives. In patients with a history of nonallergic NSAID hypersensitivity, stratified according to the severity of the symptoms, to assess with NSAIDs the predictive value of basophil (BAT) and monocyte (MAT) activation tests. Patients/Methods. Sixty patients who had NSAIDs-induced or exacerbated urticaria/angiooedema and 20 controls was included. After incubation with NSAIDs or acetaminophen, leukocytes were analysed for CD63 upregulation. Results. With aspirin, the sensitivity (37%) and specificity (90%) of BAT agree with already published results. In contrast, when patients had had cutaneous and visceral reactions, the frequency of positive BAT 14/22 (64%, P < 0.001) or MAT 10/22 (46%, P < 0.01) were increased. Conclusions. Positive tests were more frequent among patients having a severe hypersensitivity contrasting with the other patients who had results similar to controls.
机译:背景。已经描述了一种基于NSAIDs诱导的CD63上调检测的体外嗜碱细胞活化测试。其临床意义尚存争议。目标。具有非过敏性NSAID过敏史的患者,根据症状的严重程度进行分层,以NSAID评估嗜碱性粒细胞(BAT)和单核细胞(MAT)激活测试的预测价值。患者/方法。包括60名患有非甾体类抗炎药诱导或加重的荨麻疹/血管水肿的患者和20名对照。与NSAID或对乙酰氨基酚孵育后,分析白细胞CD63的上调。结果。使用阿司匹林,BAT的敏感性(37%)和特异性(90%)与已经发表的结果一致。相反,当患者发生皮肤和内脏反应时,BAT 14/22(64%,P <0.001)或MAT 10/22(46%,P <0.01)阳性的频率增加。结论。在严重超敏反应患者中,阳性测试的频率更高,而在其他情况下,其结果与对照组相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号